Aladdin Healthcare Technologies SE
Develops AI-powered tools for drug discovery and diagnostics for age-related conditions.
NMI | BE
Overview
Corporate Details
- ISIN(s):
- DE000A12ULL2
- LEI:
- 391200M0N1PWTP19RE15
- Country:
- Germany
- Address:
- Unter den Linden 10, 10117 Berlin
- Website:
- https://aladdinid.com/
Description
Aladdin Healthcare Technologies SE is a healthcare technology company that leverages artificial intelligence for drug discovery and diagnostics. The company's primary focus is on developing solutions for age-related conditions, with a significant emphasis on Alzheimer's disease. It utilizes a proprietary AI platform for virtual screening to identify novel small molecule drug compounds. In addition to drug development, the company develops AI-powered diagnostic tools and health screening services, which include applications for advanced image processing and analysis.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2020-04-06 16:00 |
Aladdin Healthcare Technologies SE: Capital increase against cash contribution …
|
English | 7.3 KB | ||
| 2020-04-02 09:00 |
DGAP-DD: Aladdin Healthcare Technologies SE english
|
English | 8.1 KB | ||
| 2020-03-30 09:00 |
Aladdin Healthcare Technologies SE launches its prototype 'Health Risk Assessme…
|
English | 10.5 KB | ||
| 2020-03-26 08:00 |
Aladdin Healthcare Technologies SE delivers Thermo-Imaging AI System for COVID-…
|
English | 10.6 KB | ||
| 2020-03-17 09:00 |
Aladdin Healthcare Technologies SE plans listing on trading platform XETRA
|
English | 9.0 KB | ||
| 2020-03-16 08:00 |
Aladdin Healthcare Technologies SE signs MOU with partner in India to validate …
|
English | 10.1 KB | ||
| 2020-03-03 16:17 |
Aladdin Healthcare Technologies SE: Kapitalerhohung gegen Bareinlage mit Bezugs…
|
German | 14.1 KB | ||
| 2020-03-03 12:06 |
Aladdin Healthcare Technologies SE: Kapitalerhohung gegen Bareinlage mit Bezugs…
|
German | 14.1 KB | ||
| 2020-03-03 09:26 |
Aladdin Healthcare Technologies SE has developed a novel prototype application …
|
English | 10.7 KB | ||
| 2020-02-07 11:03 |
Aladdin Healthcare Technologies SE: Announces the appointment of Chief Scientif…
|
English | 53.2 KB | ||
| 2020-02-04 11:59 |
Aladdin Healthcare Technologies SE: Announces we have achieved a top five posit…
|
English | 50.2 KB | ||
| 2020-01-16 10:20 |
Aladdin Healthcare Technologies SE: Announces we have developed a prototype A.I…
|
English | 23.3 KB | ||
| 2020-01-08 11:08 |
Aladdin Healthcare Technologies SE: release a SAAS prototype for Early Diagnosi…
|
English | 15.2 KB | ||
| 2019-12-12 12:50 |
Aladdin Healthcare Technologies SE: Announces it has co-published a scientific …
|
English | 7.4 KB | ||
| 2019-09-26 12:28 | English | 1.8 KB |
Automate Your Workflow. Get a real-time feed of all Aladdin Healthcare Technologies SE filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Aladdin Healthcare Technologies SE
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Aladdin Healthcare Technologies SE via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2022-02-02 | Menpes-Smith, Mr Wade | Board | Other | None | 211,425.00 EUR |
| 2021-09-21 | Continental Aktiengesellschaft | Close relation | Sell | None | 243,288.00 EUR |
| 2021-09-20 | Smith, Wade | Board | Other | None | 211,425.00 EUR |
Peer Companies
